Association of CD58 Polymorphisms and its Protein Expression with the Development and Prognosis of Autoimmune Thyroid Diseases

References

• Australia, New Zealand Multiple Sclerosis Genetics C. 2009. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 41(7):824–28.
   PubMed Web of Science ®Google Scholar
• Barbosa JA, Mentzer SJ, Kamarck ME, Hart J, Biro PA, Strominger JL, Burakoff SJ. 1986. Gene mapping and somatic cell hybrid analysis of the role of human lymphocyte function-associated antigen-3 (LFA-3) in CTL-target cell interactions. J Immunol. 136(8):3085–91.
   PubMed Web of Science ®Google Scholar
• Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA. 2005. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes. 54(5):1407–14.
   PubMed Web of Science ®Google Scholar
• Coustet B, Agarwal SK, Gourh P, Guedj M, Mayes MD, Dieude P, Wipff J, Avouac J, Hachulla E, Diot E, et al. 2011. Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts. J Rheumatol. 38(6):1033–38.
   PubMed Web of Science ®Google Scholar
• Davis SJ, van der Merwe PA. 1996. The structure and ligand interactions of CD2: implications for T-cell function. Immunol Today. 17(4):177–87.
   PubMedGoogle Scholar
• De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L, McCauley JL, Sawcer S, Goris A, Saarela J, et al. 2009. The role of the CD58 locus in multiple sclerosis. Proc Natl Acad Sci U S A. 106(13):5264–69.
   PubMed Web of Science ®Google Scholar
• El Menshawy N, Eissa M, Abdeen HM, Elkhamisy EM, Joseph N. 2018. CD58; leucocyte function adhesion-3 (LFA-3) could be used as a differentiating marker between immune and non-immune thyroid disorders. Comp Clin Path. 27(3):721–27.
   PubMedGoogle Scholar
• Haas J, Hug A, Viehover A, Fritzsching B, Falk CS, Filser A, Vetter T, Milkova L, Korporal M, Fritz B, et al. 2005. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol. 35(11):3343–52.
   PubMed Web of Science ®Google Scholar
• Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, et al. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 357:851–62.
   PubMed Web of Science ®Google Scholar
• Hong J, Li N, Zhang X, Zheng B, Zhang JZ. 2005. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci U S A. 102(18):6449–54.
   PubMed Web of Science ®Google Scholar
• Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK, Bourdette D, Ziegler SF, Offner H, Vandenbark AA. 2005. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res. 81(1):45–52.
   PubMed Web of Science ®Google Scholar
• Inoue N, Watanabe M, Morita M, Tomizawa R, Akamizu T, Tatsumi K, Hidaka Y, Iwatani Y. 2010. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin Exp Immunol. 162(3):402–06.
   PubMed Web of Science ®Google Scholar
• Janeway CA Jr., Bottomly K. 1994. Signals and signs for lymphocyte responses. Cell. 76(2):275–85.
   PubMed Web of Science ®Google Scholar
• Jenkins MK. 1994. The ups and downs of T cell costimulation. Immunity. 1(6):443–46.
   PubMed Web of Science ®Google Scholar
• Kim JY, Bae JS, Kim HJ, Shin HD. 2014. CD58 polymorphisms associated with the risk of neuromyelitis optica in a Korean population. BMC Neurol. 14:57.
   PubMed Web of Science ®Google Scholar
• Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. 2005. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes. 54(1):92–99.
   PubMed Web of Science ®Google Scholar
• Liu J, Shi Z, Lian Z, Chen H, Zhang Q, Feng H, Miao X, Du Q, Zhou H. 2017. Association of CD58 gene polymorphisms with NMO spectrum disorders in a Han Chinese population. J Neuroimmunol. 309:23–30.
   PubMed Web of Science ®Google Scholar
• Menconi F, Marcocci C, Marino M. 2014. Diagnosis and classification of Graves’ disease. Autoimmun Rev. 13:398–402.
   PubMed Web of Science ®Google Scholar
• Nakano A, Watanabe M, Iida T, Kuroda S, Matsuzuka F, Miyauchi A, Iwatani Y. 2007. Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid. 17(1):25–31.
   PubMed Web of Science ®Google Scholar
• Norcross MA. 1984. A synaptic basis for T-lymphocyte activation. Ann Immunol (Paris). 135D(2):113–34.
   PubMedGoogle Scholar
• Rubio JP, Stankovich J, Field J, Tubridy N, Marriott M, Chapman C, Bahlo M, Perera D, Johnson LJ, Tait BD, et al. 2008. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun. 9(7):624–30.
   PubMed Web of Science ®Google Scholar
• Saitoh O, Nagayama Y. 2006. Regulation of Graves’ hyperthyroidism with naturally occurring CD4+CD25+ regulatory T cells in a mouse model. Endocrinology. 147(5):2417–22.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 155(3):1151–64.
   PubMed Web of Science ®Google Scholar
• Selvaraj P, Plunkett ML, Dustin M, Sanders ME, Shaw S, Springer TA. 1987. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Nature. 326(6111):400–03.
   PubMed Web of Science ®Google Scholar
• Smith TR, Verdeil G, Marquardt K, Sherman LA. 2014. Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms. J Immunol. 193(7):3409–16.
   PubMed Web of Science ®Google Scholar
• Torbati S, Karami F, Ghaffarpour M, Zamani M. 2015. Association of CD58 polymorphism with multiple sclerosis and response to interferon ss therapy in a subset of Iranian population. Cell J. 16(4):506–13.
   PubMed Web of Science ®Google Scholar
• Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. 2004. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med. 199(7):971–79.
   PubMed Web of Science ®Google Scholar
• Wakkach A, Cottrez F, Groux H. 2001. Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J Immunol. 167(6):3107–13.
   PubMed Web of Science ®Google Scholar
• Wang JH, Smolyar A, Tan K, Liu JH, Kim M, Sun ZY, Wagner G, Reinherz EL. 1999. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell. 97(6):791–803.
   PubMed Web of Science ®Google Scholar
• Weetman AP. 2013. The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto. Eur Thyroid J. 1(4):243–50.
   PubMedGoogle Scholar